Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers.
Open Access
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 265 (9) , 4923-4928
- https://doi.org/10.1016/s0021-9258(19)34062-1
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Vascular anticoagulant β: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activityEuropean Journal of Biochemistry, 1989
- Purification and characterization of a novel protein from bovine aorta that inhibits coagulationEuropean Journal of Biochemistry, 1988
- Antibodies to the N-terminus of calpactin II (p35) affect calcium binding and phosphorylation by the epidermal growth factor receptor in vitroBiochemistry, 1988
- Prothrombin activation on phospholipid membranes with positive electrostatic potentialBiochemistry, 1988
- Predicted structure for the calcium-dependent membrane-binding proteins p35, p36 and p32Protein Engineering, Design and Selection, 1987
- Primary sequence of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortinBiochemistry, 1986
- Common domain structure of Ca2+ and lipid‐binding proteinsFEBS Letters, 1986
- Blood CoagulationAnnual Review of Biochemistry, 1980
- Lipid Asymmetry in MembranesAnnual Review of Biochemistry, 1979
- The enzymatic synthesis of phosphatidylserine and purification by CM-cellulose column chromatographyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977